BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 23541131)

  • 21. A pharmacist and health promoter team to improve medication adherence among Latinos with diabetes.
    Gerber BS; Cano AI; Caceres ML; Smith DE; Wilken LA; Michaud JB; Ruggiero LA; Sharp LK
    Ann Pharmacother; 2010 Jan; 44(1):70-9. PubMed ID: 20028957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
    Simeone JC; Quilliam BJ
    Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary evaluation of medication therapy management services in assisted living facilities in rural Minnesota.
    Scott DM; Dewey MW; Johnson TA; Kessler ML; Friesner DL
    Consult Pharm; 2010 May; 25(5):305-19. PubMed ID: 20497929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population.
    Davidson MB; Ansari A; Karlan VJ
    Diabetes Care; 2007 Feb; 30(2):224-7. PubMed ID: 17259485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The DIAB.&TE.S Project: how patients perceive diabetes and diabetes therapy.
    Marra G;
    Acta Biomed; 2004 Dec; 75(3):164-70. PubMed ID: 15796090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
    Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
    Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
    Stuart B; Shaffer TJ; Simoni-Wastila LJ; Zuckerman IH; Quinn CC
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):195-208. PubMed ID: 17996659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
    Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
    Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes outcomes in patients with poorly controlled diabetes.
    Skinner JS; Poe B; Hopper R; Boyer A; Wilkins CH
    Diabetes Educ; 2015 Aug; 41(4):459-65. PubMed ID: 26009557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a hypertension medication therapy management program in patients with diabetes.
    Planas LG; Crosby KM; Mitchell KD; Farmer KC
    J Am Pharm Assoc (2003); 2009; 49(2):164-70. PubMed ID: 19289342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nontraditional or noncentralized models of diabetes care: medication therapy management services.
    Chawla S
    J Fam Pract; 2011 Nov; 60(11 Suppl):S12-8. PubMed ID: 22336920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
    Cooke CE; Lee HY; Tong YP; Haines ST
    Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient characteristics predicting the frequency of medication therapy management visits for patients with diabetes.
    Soliman AM; Carlson AM; MacLehose RF; Brummel AR; Schommer JC
    Clin Ther; 2013 Apr; 35(4):534-40. PubMed ID: 23541131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal diabetes care outcomes following face-to-face medication therapy management services.
    Brummel AR; Soliman AM; Carlson AM; de Oliveira DR
    Popul Health Manag; 2013 Feb; 16(1):28-34. PubMed ID: 23113628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of medication therapy management on underserved, primarily Hispanic patients with diabetes.
    Congdon HB; Dowling TC; Cheng I; Truong HA
    Ann Pharmacother; 2013 May; 47(5):665-70. PubMed ID: 23585643
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.